“Media reports explain it to be a loophole,” suggests Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s very intentional coverage.” Brunner has expressed annoyance about how some coverage on the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medications or study peptides with credentialed https://williamj465jfw8.actoblog.com/profile